Avanos Medical Inc (AVNS)

Gross profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Gross profit (ttm)	US$ in thousands	392,800	456,500	461,200	465,000	467,100	407,300	397,300	381,400	366,100	353,700	359,300	360,100	370,900	394,100	393,300	405,500	402,200	392,900	402,600	398,600
Revenue (ttm)	US$ in thousands	619,900	735,200	767,700	802,100	810,000	788,200	772,300	757,500	741,300	731,000	729,200	703,100	699,300	702,400	688,900	698,200	682,600	663,500	656,500	638,800
Gross profit margin		63.37%	62.09%	60.08%	57.97%	57.67%	51.67%	51.44%	50.35%	49.39%	48.39%	49.27%	51.22%	53.04%	56.11%	57.09%	58.08%	58.92%	59.22%	61.33%	62.40%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $392,800K ÷ $619,900K
= 63.37%

Avanos Medical Inc's gross profit margin has been showing a positive trend over the past eight quarters, with an upward trajectory from Q1 2022 to Q4 2023. The company's gross profit margin increased steadily from 49.94% in Q1 2022 to 56.39% in Q4 2023, indicating an improvement in the efficiency of the company's production processes and cost management. This trend suggests that Avanos Medical Inc has been effectively managing its costs and maximizing its profitability from sales. Overall, the increasing gross profit margin reflects positively on the company's operational performance and financial health.